scholarly article | Q13442814 |
P2093 | author name string | C J Schmidt | |
C K Sullivan | |||
G M Fadayel | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
striatum | Q1319792 | ||
P304 | page(s) | 1382-1389 | |
P577 | publication date | 1994-04-01 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine | |
P478 | volume | 62 |
Q38829190 | 3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner. |
Q36334398 | 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen |
Q44962619 | 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion |
Q37012610 | Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons |
Q42712127 | Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats |
Q33819387 | Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior |
Q33187198 | Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats |
Q42025447 | Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice |
Q55066895 | Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin. |
Q35107898 | Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters |
Q40957166 | Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine |
Q36038551 | Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion: Comparison with 5-HT2A Receptor Functional Activity. |
Q36800689 | Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain |
Q37149027 | MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology |
Q41232968 | Mechanisms of action of atypical antipsychotic drugs: a critical analysis |
Q36966673 | Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. |
Q30493133 | Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission |
Q36997751 | Pharmacological models of ADHD. |
Q37800812 | Presynaptic control of serotonin on striatal dopamine function |
Q33763197 | Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease |
Q42008895 | Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration |
Q34025177 | The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine |
Q36825547 | [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand |
Search more.